All Medicines Are Poison!: Making Your Way through the Medical Minefield
Language: English
Published by AuthorHouse, 2009
- Softcover
- New

Condition: New
US$ 22.87
Quantity: Over 20 available
Add to basketItem description from seller
Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. KlappentextrnrnIn this book, All Medicines are Poison!, Melvin H. Kirschner, MPH, MD, sets out to remove the fog of confusion that clouds the landscape patients are required to navigate in their search for health care today. This book describ.
Seller Inventory # 595878664
- Title
- All Medicines Are Poison!: Making Your Way through the Medical Minefield
- Author
- Kirschner, MPH MD Melvin H.
- Publisher
- AuthorHouse
- Publication year
- 2009
- Condition
- New
- Binding
- Soft cover
- Language
- English
- ISBN 10
- 1449011659
- ISBN 13
- 9781449011659
"Synopsis" may belong to another edition of this title.
Excerpt. © Reprinted by permission. All rights reserved.
ALL MEDICINES ARE POISON!
Making Your Way through the Medical MinefieldBy MELVIN H. KIRSCHNERAuthorHouse
Copyright © 2009 Melvin H. Kirschner, MPH, MD.All right reserved.
ISBN: 978-1-4490-1165-9
Contents
Be an Informed Health Care Consumer....................................................................11. All Medicines Are Poison............................................................................32. What You Need to Know about the FDA.................................................................93. How Drugs Are Classified............................................................................194. Understanding Off-label Prescribing.................................................................295. The Scientific Method: The Gold Standard of Medicine................................................396. Why You Should Read the Package Insert..............................................................477. How Medicines Work..................................................................................538. Expiration, Interaction, and Duration...............................................................619. Side Effects and Allergic Reactions: It's Sometimes Hard to Tell the Difference.....................7110. Medicines and Treatments Must Be Thoroughly Tested.................................................8311. The Role of Sanitation in Disease Prevention.......................................................8712. What Is Informed Consent?..........................................................................9313. Antibiotics, The Wonder Drugs I Wonder If I Need One?..............................................9914. Do Placebos Have A Place In Medicine?..............................................................10515. Dosage Counts: Start Low and Go Slow...............................................................11116. Immunizations......................................................................................115Ethical Issues in Medicine.............................................................................12117. Advertising: The High Cost of Promotion............................................................12318. Why Prescription Drugs Cost So Much?...............................................................13119. Treatment Options Change Frequently................................................................14120. Doing Nothing......................................................................................14721. Conflicts of Interests: How They Affect Your Health................................................153Alternative Medicine, Not always a Good Alternative....................................................15922. Evidence-Based Medicine and Treatment..............................................................16123. High Test? Irradiated? Use Less?...................................................................16524. Poison, Cut, and Burn..............................................................................16925. Natural and Harmless...............................................................................17326. Ginkgo Biloba and Other Nonprescription Cures......................................................18127. Death by Dietary Supplements.......................................................................19328. Homeopathic, Chiropractic, And Holistic Medicine...................................................20129. A Healthy Dose of Skepticism.......................................................................209Challenges in Today's Health Care System...............................................................21330. Chemicals Essential to Life and Laboratory Tests That Identify Them................................21531. The American Health Care System....................................................................22532. The Medicare Modernization Act.....................................................................23333. "First Do No Harm": The Hippocratic Oath...........................................................239Postscript.............................................................................................247
Chapter One
BE AN INFORMED HEALTH CARE CONSUMERALL MEDICINES ARE POISON
When I was in the second year of medical school in the 1950s, we were taught about medicines and pharmacology. At the University of Southern California (USC), we were very fortunate to have a pharmacology professor of world stature, Dr. John L. Webb. During our first year, while we were learning our basic medical sciences, he was visiting Maoist Red China, studying traditional Chinese medicines. Able to speak fluent Chinese, he was one of the rare Americans invited to China during the Mao era. We met him for the first time as we assembled for our initial class in pharmacology.
The setting was somewhat strange. At that time, the new medical school campus was just starting construction across the street from Los Angeles County General Hospital. Most of our classes were held in the old chemistry building at the main USC campus, which was across town from the planned new medical school location. The old chemistry building was so overcrowded that the pharmacology class had to be held in the cavernous general assembly auditorium on campus. It was designed to accommodate at least a thousand students.
In those days, our medical school class of fifty-eight was mostly male. There were only three female students. Today, medical school classes at USC are split about fifty-fifty. We were seated in a dimly lit corner of the large auditorium. Professor Webb was on the stage, standing behind a brightly lit lectern. He presented a rather commanding figure as he looked down at us for the first time.
"Ladies and gentlemen," he said, "I am here to teach you how to poison people!"
A brief pause followed while we sat stunned by those words. We were expecting to learn how to cure people, not poison them.
Then he added, "Without killing them, of course."
Thus, the title of this book originates from Dr. Webb's introduction to pharmacology. There followed a discussion of why and how all medicines are poison in some situations. I have never forgotten that lesson in the more than fifty years since I heard that statement. Years of medical practice have validated repeatedly what Dr. Webb taught us about medicines. Throughout that semester, he taught us to appreciate the uses and benefits that medicines have, but also the burdens (adverse reactions) they could cause and their interactions with other substances.
Properly used medicines are of great benefit and save lives, but we must always be aware of the burdens. Furthermore anything we ingest can cause problems. With this benefits-versus-burdens relationship in mind, we make our health decisions. Physicians are expected to educate patients about these matters. In our society, doctors advise, and patients decide.
When I was a child, tincture of iodine came in a unique brown bottle with a skull and crossbones embossed on its side. The skull and crossbones implied danger, poison, and even death. In those days, tincture of iodine was widely used as an antiseptic for cuts and abrasions. It stung when it was applied, but not from the iodine. The sting was from the alcohol it contained. It was painted on cuts and lacerations to keep them from becoming infected. Iodine is still used, but in an aqueous solution that is still an excellent antiseptic. Without alcohol as the solvent, it doesn't burn when applied to a wound.
In the tincture of iodine days, we kids preferred Mercurochrome. It could be applied to a wound without causing the burning pain that iodine caused. It also prevented infection, and it wasn't marked as poison. In fact, Mercurochrome was a mercury compound, and it was a poison, but the bottle did not have a skull and crossbones embossed on it. The likelihood of actually becoming poisoned by the mercury in Mercurochrome was remote. One used a small amount on the wound, and it was never ingested.
Humans have used mercury in many forms. Thiomersal, an organic mercury compound, was used for many years as a preservative of drugs in sterile ampules (small glass bottles) that held several doses prior to injection. Some authorities suspected thiomersal in immunizing vaccines was causing autism in children. The Food and Drug Administration (FDA) has ordered that thiomersal be removed from injectable medications. Studies have shown that thiomersal does not cause autism, but this chemical substance has never found its way back into pediatric immunization vaccines. They now do not contain mercury.
Another mercury hazard exists in certain fish that feed in mercury-contaminated waters. The FDA and Environmental Protection Agency (EPA) have jointly issued a warning suggesting to the public (and especially pregnant women) to avoid eating certain fish that contain excessive amounts of mercury. The list includes shark, swordfish, tilefish, and king mackerel. These fish are known to concentrate the ingested mercury in their flesh. In theory, eating large quantities of these varieties of fish may present a hazard. It doesn't seem to bother the fish. By my calculation, one would need to eat an awfully lot of mercury-contaminated fish over a long period to reach a dangerous level of poisoning. Recently, pregnant women and children have been especially advised to limit their consumption of tuna. This information is detailed on the Internet at the FDA's Web site.
Another issue widely discussed in the dental literature, is the use of amalgams to fill cavities in teeth. Amalgams are compounded with mercury. Some dentists advocate removing all the amalgams and replacing them with mercury-free substances. This practice is based on the theory that the mercury in the amalgam is slowly absorbed from the tooth into the patient's body, thus causing a toxic reaction. Most dentists do not believe this because mercury poisoning has not been demonstrated in people who have had amalgams in their fillings for many years. The American Dental Association (ADA) and most dentists regard it as unnecessary to replace amalgams with fillings that do not contain mercury.
The National Council Against Health Fraud (NCAHF) published a position paper on the subject of amalgams on its Web site at www.ncahf.org. The dentists on the board of the NCAHF agree with the Council's position paper, which recommends against the removal of fillings containing mercury.
Iodine and mercury are two examples of natural substances that have been found beneficial in one setting but present risks and burdens that must be considered when they are used for other purposes.
WHAT YOU NEED TO KNOW ABOUT THE FDA
Prior to 1906, when the Pure Food and Drug Act came into existence, the use of medications by patients and doctors was essentially a buyer-beware market. Hucksters could sell anything and make any statement about the use and contents of their products, whether true or false.
Journalists of the time and books such as The Jungle by Upton Sinclair influenced Congress. The book vividly described the terrible sanitation and contamination of the food products the meatpacking industry of the time was producing. A complete copy of this text is still available on the Internet more than one hundred years since it was first published. In response to the poor sanitation and purity of the food being produced at the time, Congress created the FDA in 1906. This agency's mandate was to see that foods and drugs were not adulterated or misbranded.
In 1912, Congress added an amendment that specifically prohibited "false and fraudulent" curative or therapeutic claims on the label. In 1938, the Federal Food, Drug, and Cosmetic Act was passed. For the first time, the FDA required that, before marketing a new drug, a manufacturer had to submit evidence that the drug was safe and effective.
ANOTHER STEP TOWARD PATIENT SAFETY
The Kefauver-Harris Amendment of 1962 represented another major step forward for patient safety. Among other requirements, the Kefauver-Harris Amendment mandated the inclusion of complete professional information in virtually all prescription drug packages and sales literature distributed to physicians.
At that time, I had been in practice for only two years. As a new doctor, I found the description of hazards, side effects, and precautions to be very helpful in prescribing safely and appropriately. Detailed descriptions now accompany all prescription medicines. They are known as "package inserts," and they are extremely complex and somewhat confusing. Doctors have been accused of not reading them carefully enough before prescribing a new medication, so the FDA is currently in the process of revising the format so important prescribing information, such as adverse reactions and interactions, are displayed more prominently and made easier for physicians to review.
I read and reread this information and carry a pocket prescription drug reference (pocket PDR) with me at all times, yet the prescriptions I write still sometimes cause unanticipated adverse reactions. The number of humans studied during the required pre-release research period is relatively small. When millions of people start to use a new medicine after it is released for general use, unexpected side effects, interactions, and hazards surface.
For this reason, in the 1970s, the Drug Quality Reporting System (DQRS) was established, and pharmacists and physicians began reporting adverse reactions. The information garnered from these reports makes it possible for the FDA to monitor and even recall products that prove to be unsafe after their release.
THE STANDARD DRUG APPROVAL PROCESS
Drug companies spend millions of dollars researching new products. The company that is first to market a new class of medication is likely to make more profits than later competitors are. The drug approval process was tediously slow. This was necessitated by the methods required by the FDA to assure new drugs reach the market only after careful and thorough evaluation.
The FDA's Center for Drug Evaluation and Research (CDER) requires a standard protocol for studying potentially new drugs. Each proposed new substance is first subjected to animal studies in at least two species. This pharmacology/toxicology testing is to develop adequate data to undergird a decision that it is reasonably safe to proceed with human trials.
The first human clinical studies (Phase I) may be conducted in patients, and they are usually done in human volunteers. These studies, usually conducted on twenty to eighty subjects, are designed to evaluate drug metabolism and mechanism of action in humans. Side effects of increasing doses are also evaluated at this phase.
Phase II includes controlled clinical studies that are conducted to obtain preliminary data on the effectiveness of the drug for a particular indication in patients with the disease or condition. This phase of testing also helps determine the common short-term effects and risks associated with the drug. Phase II studies usually involve several hundred people.
If the Phase II studies do not eliminate a new drug, it then goes on to Phase III. These clinical studies are intended to gather additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug. Phase III studies also provide information for inclusion in the product brochure being prepared for doctors who will be prescribing the new drug. This phase usually includes several hundred to several thousand people.
The real test of a drug is when it is approved for marketing and millions of patients use it. The FDA is aware that no amount of careful preapproval testing will reveal all of the risks and adverse reactions. So physicians are encouraged to report adverse reactions and effects not already described in the product brochure that accompanies prescription drugs.
When such reports are made, the FDA evaluates their frequency and significance. Reports of a serious nature have resulted in the addition of a black box warning to the product brochures and, at times, recall of the drug from the market. Side effects appear in the adverse reactions section of the brochure.
Enlisting adequate numbers of qualified volunteers for clinical trials has been a problem. In the past, clinical trials have primarily been done at the university clinics, but, in recent years, community-based physicians have done much research. Unfortunately, unscrupulous individuals have sometimes failed to follow the rigid requirements of valid research. Some well-meaning physicians who have been asked to participate in clinical trials or refer their patients do not understand the ethics involved.
The Los Angeles County Medical Association/Bar Association Joint Committee on Biomedical Ethics developed "Guidelines for Physicians Participating in Clinical Trials." With these guidelines, the committee hopes to provide a set of ethical standards that can be followed so physicians understand their ethical role and the patient is neither harmed nor misinformed.
These guidelines made it very clear that issues of informed consent, privacy, institutional review committee oversight, and other safeguards are in place before any human experimentation can be done in this society. This is a very touchy subject, which involves medical ethics, as all of the Committee's guidelines do.
An e-mail newsletter addressed primarily to physicians, "ePocrates Clinical Trials Connection," discussed the issue of clinical trials, stating that 80 percent of all trials are delayed due to poor recruitment. According to ePocrates News, in 2001, there were twelve hundred drugs in Phase III clinical trials. Only twenty-four new drugs and twenty-seven new drug formulations or combinations were approved that year.
CDER monitors study design and conduct of clinical trials to ensure people in the trials are not exposed to unnecessary risks.
I will later discuss informed consent, a critical component of all treatment and medical care in the United States. Obtaining the patient's informed consent is also required for clinical trial research. This requirement originates from the patient's legal and ethical right to direct what happens to his or her body. The language used to obtain consent must be in clearly understandable lay terminology.
THE PRACTICE OF FAST TRACKING
Another factor has entered the equation in recent years. The public has been demanding that drugs that show promise of helping critically and seriously ill patients be released before the required comprehensive studies are completed. This is commonly known as "fast tracking."
I agree with this practice, as the patients on whose behalf this is done are dying or suffering terribly and grasping at straws. But I do object to fast tracking drugs that are rushed to market before the benefits and side effects are well studied and understood solely because early release promotes profits.
Please don't read me wrong. Patients have greatly benefited from the many wonderful new medications that this industry has produced. But, as a physician, I must think of patient welfare first. I do not believe it is necessary to hasten a new drug to market when the condition it is intended to treat isn't life threatening or other effective medicines already exist.
Obviously, diseases such as AIDS, metastatic cancer, and other illnesses that lead to a painful and miserable death prompted the development of fast track standards. The language in the fast track rules that permitted other medications intended to treat nonfatal conditions to attain fact track status is in this statement that I quote from the FDA's fact track requirements:
The fast track programs of the FDA are designed to facilitate the development and expedite review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs.
(Continues...)
Excerpted from ALL MEDICINES ARE POISON!by MELVIN H. KIRSCHNER Copyright © 2009 by Melvin H. Kirschner, MPH, MD.. Excerpted by permission.
All rights reserved. No part of this excerpt may be reproduced or reprinted without permission in writing from the publisher.
Excerpts are provided by Dial-A-Book Inc. solely for the personal use of visitors to this web site.
"About the title" may belong to another edition of this title.
Shipping rates from Germany to U.S.A.
| Item | 16 to 45 business days | 16 to 45 business days |
|---|---|---|
| First item | US$ 53.88 | US$ 53.88 |
Payment methods
- Bank Wire Transfer
- Check
- Paypal
Store description
Online Handel nur mit Neubüchern
Seller's business information
Moluna GmbH
Engberdingdamm 27
Greven, Germany 48268
Terms of sale
Instructions for revocation/
Standard Business Terms and customer information/ data protection declaration
Revocation right for consumers
(A ‘consumer’ is any natural person who concludes a legal transaction which, to an overwhelming extent, cannot be attributed to either his commercial or independent professional activities.)
Instructions for revocation
Revocation right
You have the right to revoke this contract within one month without specifying any reasons.
The revocation period is one month with effect from the day,
-
on which you or a third party nominated by you, which is not the carrier, had taken possession of the products, provided you had ordered one or more products within the scope of a standard order and this/these product/products is/are delivered uniformly;
-
on which you or a third party nominated by you, which is not the carrier, had taken possession of the last product, provided you had ordered several products within the scope of a standard order and these products are delivered separately;
-
on which you or a third party nominated by you, which is not the carrier, had taken possession of the last part delivery or the last unit, provided you had ordered a product, which is delivered in several part deliveries or units;
In order to exercise your revocation right, you must inform us (Moluna GmbH, Engberdingdamm 27, 48268 Greven, Telephone number: 02571/5 69 89 33, Fax number: 02571/5 69 89 30, E-Mail address: abe@moluna.de) of your decision to revoke this contract by means of a clear declaration (e.g. a letter sent via post, fax or email). You can use the enclosed specimen revocation form for this, which however is not mandatory.
In order to safeguard the revocation period, it is sufficient that you send the notification about the exercise of the revocation right before the expiry of the revocation period.
Consequences of the revocation
If you revoke this contract, we shall repay all the payments, which we received from you, including the delivery costs (with the exception of additional costs, which arise from that fact that you selected a form of delivery other than the most reasonable standard delivery offered by us), immediately and at the latest within 14 days from the day on which we received the notification about the revocation of this contract from you. We use the same means of payment, which you had originally used during the original transaction, for this repayment unless expressly agreed otherwise with you; you will not be charged any fees owing to this repayment.
We can refuse the repayment until the products are returned to us or until you have furnished evidence that you have sent the products back to us, depending on whichever is earlier.
You must return or transfer the products to us immediately and, in any case, at the latest within 14 days with effect from the day on which you inform us of the revocation of this contract. The deadline is maintained if you send the products before the expiry of the 14 day deadline.
You bear the direct costs for returning the products.
You must pay for any depreciation of the products only if this depreciation can be attributed to any handling with you that was not necessary for checking the condition, features and functionality of the products.
Criteria for exclusion or expiry
The revocation right is not available for contracts
for delivery of products, which are not prefabricated and for whose manufacturing an individual selection or stipulation by the consumer is important or which are clearly tailored to the personal requirements of the consumer;
for delivery of products, which can spoil quickly or whose use-by date would be exceeded quickly;
for delivery of alcoholic drinks, whose price was agreed at the time of concluding the contract, which however can be delivered 30 days after the conclusion of the contract at the earliest and whose current value depends on the fluctuations in the market, on which the entrepreneur has no influence;
for delivery of newspapers, periodicals or magazines with the exception of subscription contracts.
The revocation right expires prematurely in case of contracts
for delivery of sealed products, which are not suitable for return for reasons of health protection or hygiene if their seal has been removed after the delivery;
for delivery of products if they have been mixed inseparably with other goods after the delivery, owing to their condition;
for delivery of sound or video recording or computer software in a sealed package if the seal has been removed after the delivery.
Specimen - revocation form
(If you wish to revoke the contract, please fill up this form and send it back to us.)
-
To Moluna GmbH, Münsterstr. 105, 48268 Greven, Fax number: 02571/5 69 89 30, Email address: abe@moluna.de :
-
I/we () herewith revoke the contract concluded by me/ us () regarding the purchase of the following products ()/
the provision of the following service () -
Ordered on ()/ received on ()
-
Name of the consumer(s)
-
Address of the consumer(s)
-
Signature of the consumer(s) (only in case of a notification on paper)
-
Date
(*) Cross out the incorrect option.
Standard Business Terms and customer information / data protection declaration
I. Standard business terms
§ 1 Basic provisions
(1) The following terms and conditions of business apply for all contracts concluded with us as the supplier (Moluna GmbH) via the websites AbeBooks and/or ZVAB. Unless otherwise agreed, the inclusion of your own terms and conditions is explicitly rejected.
(2) A ‘consumer’ in the sense of the following regulations is every natural person who concludes a legal transaction which, to an overwhelming extent, cannot be attributed to either his commercial or independent professional activities. The term ‘businessman’ refers to every natural person, legal person or legally responsible partnership that concludes a legal transaction in pursuance of his/its independent professional or commercial activity.
§ 2 Conclusion of the contract
(1) The subject-matter of the contract is the selling of products .
(2) If an article is placed by us with AbeBooks or ZVAB, the activation of the page on AbeBooks or ZVAB shall involve the binding offer to conclude a contract under the terms and conditions contained in the article page.
(3) The contract shall become effective via the online shopping cart system as follows:
The products intended for purchase are moved to the "shopping cart". You can select the "Shopping Cart" using the appropriate buttons on the navigation bar and make changes there at any time.
After calling up the “Checkout” page and entering the required personal data and payment and shipping conditions, all order information is then displayed again on the order summary page.
Before submitting the order, you have the ability once more to review or change any information here (you may also use the "back" button on the Internet browser), or to cancel the purchase.
By clicking the “Buy now” button to submit the order, you declare your legally binding acceptance of the order which makes the contract effective.
(4) The execution of the order and the sending of all the details necessitated by the conclusion of the contract take place via e-mail, in a partially-automated manner. Consequently, you have to ensure that the e-mail address that you have deposited with us is the correct one, and that the receipt of the respective e-mails is guaranteed. In particular, you have to ensure that the respective e-mails are not blocked by a SPAM filter.
§ 3 Right of retention, reservation of proprietary rights
(1) You can only exercise a right of retention if the situation in question involves claims arising from the same contractual relationship.
(2) The goods remain our property until the purchase price is paid in full.
(3) If you are a businessman, the following conditions also apply:
a) We retain ownership of the goods until all the claims arising from the ongoing business relationship have been settled in full. The goods subject to retention of title may not be pledged or transferred by way of security before ownership of the said goods changes hands.
b) You can re-sell the goods within the framework of an orderly transaction. In this regard, you hereby cede all the claims amounting to the magnitude of the billing amount that accrue to you as a result of the re-selling operation to us, and we accept the cession. Furthermore, you are authorised to collect the claim in question. However, insofar as you do not discharge your payment obligations in an orderly fashion, we reserve the right to collect the claim ourselves.
c) In a situation involving the combination and amalgamation of the goods subject to retention of title, we acquire co-ownership of the newly-formed item. This co-ownership corresponds to the ratio that exists between the invoice value of the goods subject to retention of title and the other processed items at the time of processing.
d) If you make a request of this nature, we shall be obligated to release the securities that are due to us, to the extent that the realisable value of our securities exceeds the claim to be secured by more than 10%. We are responsible for selecting the securities to be released.
§ 4 Warranty
(1) The statutory warranty rights are applicable.
(2) As a consumer, you are requested to promptly check the product for completeness, visible defects and transport damage as soon as it is delivered, and promptly disclose your complaints to us and the shipping company in writing. Even if you do not comply with this request, it shall have no effect on your legal warranty claims.
(3) If a characteristic of the goods deviates from the objective requirements, the deviation shall only be deemed to be agreed if you were informed of the same by us before submitting the contractual declaration and the deviation was expressly and separately agreed between the contracting parties.
(4)
Insofar as you are an entrepreneur, the following shall apply in deviation from the above warranty provisions:
a) Only our own specifications and the manufacturer's product description shall be deemed agreed as the quality of the goods, but not other advertising, public promotions and statements by the manufacturer.
b) In the event of defects, we shall, at our discretion, provide warranty by rectification of the defect or subsequent delivery. If the rectification of defects fails, you may, at your option, demand a reduction in price or withdraw from the contract. The rectification of defects shall be deemed to have failed after a second unsuccessful attempt, unless the nature of the goods or the defect or other circumstances indicate otherwise. In the event of rectification of defects, we shall not be obliged to bear the increased costs arising from the transport of the goods to a place other than the place of performance, unless such transport is in accordance with the intended use of the goods.
c) The warranty period shall be one year from delivery of the goods. The shortening of the period shall not apply
- for culpable damage attributable to us arising from injury to life, limb or health and for other damage caused intentionally or by gross negligence;
- insofar as we have fraudulently concealed the defect or have assumed a guarantee for the quality of the item;
- in the case of items which have been used for a building in accordance with their customary use and have caused its defectiveness;
- in the case of statutory rights of recourse that you may assert against us in connection with rights arising from defects.
§ 5 Choice of law, place of fulfilment, jurisdiction
(1) German law shall apply. This choice of law only applies to customers if it does not result in the revocation of the protection guaranteed by the mandatory provisions of the law of the country in which the respective customer’s usual place of residence is located (benefit-of-the-doubt principle).
(2) If you are not a consumer, but a businessman, a legal entity under public law or an institutional fund governed by public law, our place of business is the place of jurisdiction as well as the place of fulfilment for all services that follow from the business relationships that exist with us. The same condition applies to situations in which you are not associated with a general place of jurisdiction in Germany or the EU, as well as situations in which the place of residence or the usual place of residence is not known at the time of commencement of proceedings. This has no bearing on the capacity to call upon the court associated with another place of jurisdiction.
(3) The provisions of the UN Convention on Contracts for the International Sale of Goods are explicitly inapplicable.
II. Customer information
- Identity of the seller
Moluna GmbH
Engberdingdamm 27
48268 Greven
Germany
Telephone: 02571/5698933
E-Mail: abe@moluna.de
- Information regarding the conclusion of the contract
The technical steps associated with the conclusion of the contract, the contract conclusion itself and the correction options are executed in accordance to the regulations "conclusion of the contract" in our standard business terms (part I.).
- Contractual language, saving the text of the contract
3.1 Contract language shall be English.
3.2 The complete text of the contract is not saved with us. Before the order is sent, the contract data can be printed out or electronically saved using the browser’s print function. After the order is received by us, the order data, the legally-mandated details related to distance selling contracts and the standard business terms are re-sent to you via e-mail.
- Main features of the product or service
The key features of the goods and/or services can be found in the respective quote.
- Prices and payment arrangements
5.1 The prices mentioned in the respective offers represent total prices, as do the shipping costs. They include all the price components, including all the incidental taxes.
5.2 The dispatch costs that are incurred are not included in the purchase price. They can be viewed by clicking the appropriate button on our website or in the respective quote, are shown separately over the course of the order transaction and must additionally be borne by you, insofar as free delivery is not confirmed.
5.3 The payment methods that are available to you are shown by clicking the appropriate button on our website or are disclosed in the respective quote.
5.4 Unless otherwise specified for the respective payment methods, the payment claims arising from the contract that has been concluded become payable immediately.
- Delivery conditions
6.1 The delivery conditions, delivery date and existing supply restrictions, if applicable, can be found by clicking the appropriate button on our website or in the respective quote.
Unless a different period is specified in the item description or our delivery conditions, the goods are delivered within 3-5 days after the conclusion of the contract (in case an advance payment has been agreed upon, after the payment authorisation).
6.2 If you are a consumer, the following is statutorily regulated: The risk of the sold item accidentally being destroyed or degraded during shipping only passes over to you when the item in question is delivered, regardless of whether or not the shipping operation is insured. This condition does not apply if you have independently commissioned a transport company that has not been specified by us or a person who has otherwise been appointed to execute the shipping operation.
If you are a businessman, the delivery and shipping operations take place at your own risk.
- Statutory warranty right
Liability for defects is governed by the “Warranty” provisions in our General Terms and Conditions of Business (Part I).
last update: 01.01.2022
Data protection declaration
Unless stated otherwise below, the provision of your personal data is neither legally nor contractually obligatory, nor required for conclusion of a contract. You are not obliged to provide your data. Not providing it will have no consequences. This only applies as long as the processing procedures below do not state otherwise.
“Personal data” is any information relating to an identified or identifiable natural person.
Responsible person
Contact us at any time. The contact details of the person responsible for data processing can be found in our legal notice.
Collection, processing, and transfer of personal data in orders
When you submit an order we only collect and use your personal data insofar as this is necessary for the fulfilment and handling of your order as well as processing of your queries. The provision of data is necessary for conclusion of a contract. Failure to provide it will prevent the conclusion of any contract. The processing will occur on the basis of Article 6(1) b) GDPR and is required for the fulfilment of a contract with you.
Your data is transferred here for example to the shipping companies and dropshipping providers, payment service providers, service providers for handling the order and IT service providers that you have selected. We will comply strictly with legal requirements in every case. The scope of data transmission is restricted to a minimum.
Duration of storage
After contractual processing has been completed, the data is initially stored for the duration of the warranty period, then in accordance with the retention periods prescribed by law, especially tax and commercial law, and then deleted after the period has elapsed, unless you have agreed to further processing and use.
Rights of the affected person
If the legal requirements are fulfilled, you have the following rights according to art. 15 to 20 GDPR: Right to information, correction, deletion, restriction of processing, data portability. You also have a right of objection against processing based on art. 6 (1) GDPR, and to processing for the purposes of direct marketing, according to art. 21 (1) GDPR.
Right to complain to the regulatory authority
You have the right to complain to the regulatory authority according to art. 77 GDPR if you believe that your data is not being processed legally.
Right to object
If the data processing outlined here is based on our legitimate interests in accordance with Article 6(1)f) GDPR, you have the right for reasons arising from your particular situation to object at any time to the processing of your data with future effect.
If the objection is successful, we will no longer process the personal data, unless we can demonstrate compelling legitimate grounds for the processing that outweigh your interests or rights and freedoms, or the processing is intended for the assertion, exercise or defence of legal claims.
last update: 10.01.2022